Year: 2021
Type: review
Abstract: The acronym nonalcoholic fatty-liver disease (NAFLD) groups a heterogeneous patient population. Although in many patients the primary driver is metabolic dysfunction, a complex and dynamic interaction of different factors (i.e., sex, presence of one or more genetic variants, coexistence of different comorbidities, diverse microbiota composition, and various degrees of alcohol consumption among others) takes place to determine disease subphenotypes with distinct natural history and prognosis and, eventually, different response to therapy. This review aims to address this topic through the analysis of existing data on the differential contribution of known factors to the pathogenesis and clinical expression of NAFLD, thus determining the different clinical subphenotypes observed in practice. To improve our understanding of NAFLD heterogeneity and the dominant drivers of disease in patient subgroups would predictably impact on the development of more precision-targeted therapies for NAFLD.
Source: Seminars in Liver Disease
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funders: European Commission, Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro, Fondo Nacional de Ciencia y Tecnología, National Institutes of Health, Comisión Nacional de Investigación Científica y Tecnológica, National Institute on Alcohol Abuse and Alcoholism, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G1283076252, G2033729083, G298858806, Gain of function mutations in inflammasome related genes in human and experimental alcoholic liver disease, G434337789, G5145235585, European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development, G6842761660, G7183311485, G7329786825, Sterile inflammation and pyroptotic cell death in liver fibrosis
OpenAlex ID: W3181971717
